A pilot study of a new thrombolytic agent for acute ischemic stroke in Taiwan within a five-hour window

Stroke

Volumn 37, Issue 3, 2006, Pages 918-919

  Hu, Han Hwa ^a   Teng, Michael Mu Huo ^a   Hsu, Li Chi ^a   Wong, Wen Jang ^a   Wang, Lee Min ^a   Luk, Yun On ^a   Chern, Chang Ming ^a   Soong, Bing Wen ^a   Sheng, Wen Yung ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Stroke, ischemic; Thrombolytic therapy

Indexed keywords

FIBRINOLYTIC AGENT; HUMAN TISSUE UROKINASE TYPE PLASMINOGEN ACTIVATOR; NEW DRUG; UNCLASSIFIED DRUG; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BOLUS INJECTION; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; ECCHYMOSIS; FEMALE; GINGIVA BLEEDING; HEMATURIA; HUMAN; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PILOT STUDY; PRIORITY JOURNAL; TAIWAN; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING; BRAIN ISCHEMIA; FIBRINOLYTIC THERAPY; HOSPITALIZATION; INCIDENCE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; TIME;

AGED; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; TAIWAN; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR;

EID: 33645089965     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000202591.18871.f7     Document Type: Article

References (13)

1. American Heart Association. Heart and Stroke Fact Statistics: 1999 Statistical Supplement. Dallas, Tex: American Heart Association; 1999.
2. Murray CJL, Lopez AD, eds. The Global Burden of Disease. Vol 1. Boston, Mass: Harvard University Press; 1996.
3. Hu HH, Sheng WY, Chu FL, Lan CF, Chiang BN. Incidence of stroke in Taiwan. Stoke. 1992;23:1237-1241.
4. Lee SG, Kalyan N, Wilhelm J, Hum WT, Rappaport R, Cheng SM, Dheer S, Urbano C, Hartzell RW, Ronchetti-Blume M, et al. Construction and expression of hybrid plasminogen activators prepared from tissue-type plasminogen activator and urokinase-type plasminogen activator genes. J Biol Chem. 1988;263:2917-2924.
5. Fu KP, Lee S, Hetzel N, Fenichel R, Hum HW, Speth J, Kalyan N, Hung PP. Clearance of a novel recombinant tissue plasminogen activator in rabbits. Thromb Res. 1988;50:679-685.
6. Weinheimer CJ, James HL, Kalyan NK, Wilhelm J, Lee SG, Hung PP, Sobel BE, Bergmann SR. Induction of sustained patency after clot-selective coronary thrombolysis with Hybrid-B, a Genetically Engineered plasminogen activator with a prolonged biological half-life. Circulation. 1991;83:1429-1436.
7. Adams HP, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke. Stroke. 1996;27:1711-1718.
8. Albanese MA, Clarke WR, Adams HP Jr, Woolson RF. Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke. 1994;25:1746-1751.
9. Feldmann E, Daneault N, Kwan E, Ho KJ, Pessin MS, Langenberg P, Caplan LR. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology. 1990;40:1541-1545.
10. Tanaka H, Hayashi M, Date C, Imai K, Asada M, Shoji H, Okazaki K, Yamamoto H, Yoshikawa K, Shimada T, et al. Epidemiologic studies of stroke in Shibata, a Japanese provincial city: preliminary report on risk factors for cerebral infarction. Stroke. 1985;16:773-780.
11. Gross CR, Kase CS, Mohr JP, Cunningham SC, Baker WE. Stroke in south Alabama: incidence and diagnostic features - a population-based study. Stroke. 1984;15:249-255.
12. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
13. Albers GW, Clark WM, Madden KP, Hamilton SA. ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Stroke. 2002;33:493-496.